

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 7.30263668 |
| 2 | * antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 7.30263668 |
| 3 | * antigen processing and presentation of endogenous antigen (GO:0019883) | 6.87629728 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.05174173 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.16352440 |
| 6 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.60300835 |
| 7 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.51287738 |
| 8 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.49637970 |
| 9 | response to type I interferon (GO:0034340) | 4.48649561 |
| 10 | cellular response to type I interferon (GO:0071357) | 4.44707836 |
| 11 | type I interferon signaling pathway (GO:0060337) | 4.44707836 |
| 12 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.41087875 |
| 13 | regulation of gamma-delta T cell activation (GO:0046643) | 4.38530547 |
| 14 | detection of other organism (GO:0098543) | 4.35338507 |
| 15 | detection of bacterium (GO:0016045) | 4.30949175 |
| 16 | negative thymic T cell selection (GO:0045060) | 4.30005741 |
| 17 | negative T cell selection (GO:0043383) | 4.25687827 |
| 18 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 4.13321320 |
| 19 | NIK/NF-kappaB signaling (GO:0038061) | 4.04232539 |
| 20 | macrophage activation involved in immune response (GO:0002281) | 4.01835434 |
| 21 | T cell migration (GO:0072678) | 3.99125603 |
| 22 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.98236186 |
| 23 | positive thymic T cell selection (GO:0045059) | 3.97774083 |
| 24 | positive regulation of B cell differentiation (GO:0045579) | 3.94891846 |
| 25 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.85568393 |
| 26 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.78565788 |
| 27 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.76263215 |
| 28 | response to peptidoglycan (GO:0032494) | 3.76225738 |
| 29 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.75979412 |
| 30 | leukocyte aggregation (GO:0070486) | 3.73563966 |
| 31 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.73104963 |
| 32 | regulation of B cell differentiation (GO:0045577) | 3.70618236 |
| 33 | response to interleukin-15 (GO:0070672) | 3.68887985 |
| 34 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.68456527 |
| 35 | thymic T cell selection (GO:0045061) | 3.68051781 |
| 36 | immunoglobulin mediated immune response (GO:0016064) | 3.62569776 |
| 37 | positive regulation of interferon-alpha production (GO:0032727) | 3.60470240 |
| 38 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 3.58668769 |
| 39 | negative regulation of T cell mediated immunity (GO:0002710) | 3.58179077 |
| 40 | detection of external biotic stimulus (GO:0098581) | 3.55077136 |
| 41 | cellular response to interferon-beta (GO:0035458) | 3.52747037 |
| 42 | positive regulation of antigen processing and presentation (GO:0002579) | 3.50944941 |
| 43 | B cell receptor signaling pathway (GO:0050853) | 3.49542731 |
| 44 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.49003669 |
| 45 | negative regulation of cell killing (GO:0031342) | 3.46535770 |
| 46 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.46535770 |
| 47 | T cell selection (GO:0045058) | 3.46156499 |
| 48 | germinal center formation (GO:0002467) | 3.44328715 |
| 49 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.43972252 |
| 50 | regulation of interferon-alpha production (GO:0032647) | 3.43724980 |
| 51 | defense response to protozoan (GO:0042832) | 3.37284462 |
| 52 | regulation of tolerance induction (GO:0002643) | 3.37065999 |
| 53 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.34553635 |
| 54 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.33044047 |
| 55 | regulation of response to interferon-gamma (GO:0060330) | 3.32514279 |
| 56 | response to protozoan (GO:0001562) | 3.28498369 |
| 57 | response to interferon-beta (GO:0035456) | 3.28118772 |
| 58 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.27752378 |
| 59 | interferon-gamma production (GO:0032609) | 3.27582023 |
| 60 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.27520057 |
| 61 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.25921788 |
| 62 | myeloid dendritic cell activation (GO:0001773) | 3.23428884 |
| 63 | regulation of T cell tolerance induction (GO:0002664) | 3.22574615 |
| 64 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.21188442 |
| 65 | response to host immune response (GO:0052572) | 3.21188442 |
| 66 | positive regulation of type 2 immune response (GO:0002830) | 3.20565707 |
| 67 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.18676645 |
| 68 | positive T cell selection (GO:0043368) | 3.18406529 |
| 69 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.16490781 |
| 70 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.16490781 |
| 71 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.14587112 |
| 72 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.14300344 |
| 73 | cellular response to interleukin-15 (GO:0071350) | 3.11771213 |
| 74 | myeloid dendritic cell differentiation (GO:0043011) | 3.11014535 |
| 75 | negative regulation of innate immune response (GO:0045824) | 3.11004022 |
| 76 | detection of biotic stimulus (GO:0009595) | 3.10982192 |
| 77 | positive regulation of interleukin-2 production (GO:0032743) | 3.10761048 |
| 78 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.09935139 |
| 79 | detection of molecule of bacterial origin (GO:0032490) | 3.09574826 |
| 80 | regulation of antigen processing and presentation (GO:0002577) | 3.07578386 |
| 81 | response to interferon-alpha (GO:0035455) | 3.06695734 |
| 82 | B cell mediated immunity (GO:0019724) | 3.06594881 |
| 83 | tolerance induction (GO:0002507) | 3.05829508 |
| 84 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.05776157 |
| 85 | negative regulation of viral genome replication (GO:0045071) | 3.05418268 |
| 86 | ribosomal small subunit assembly (GO:0000028) | 3.05396236 |
| 87 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.03433611 |
| 88 | T cell costimulation (GO:0031295) | 3.01749853 |
| 89 | positive regulation of humoral immune response (GO:0002922) | 3.01692598 |
| 90 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.00893774 |
| 91 | modulation by symbiont of host immune response (GO:0052553) | 3.00893774 |
| 92 | positive regulation by symbiont of host defense response (GO:0052509) | 3.00893774 |
| 93 | modulation by symbiont of host defense response (GO:0052031) | 3.00893774 |
| 94 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.00893774 |
| 95 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.00893774 |
| 96 | T cell homeostasis (GO:0043029) | 3.00371176 |
| 97 | response to host (GO:0075136) | 2.98977059 |
| 98 | response to host defenses (GO:0052200) | 2.98977059 |
| 99 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.98977059 |
| 100 | positive regulation of isotype switching (GO:0045830) | 2.98651378 |
| 101 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.97819450 |
| 102 | response to interferon-gamma (GO:0034341) | 2.97385210 |
| 103 | regulation of RIG-I signaling pathway (GO:0039535) | 2.96736340 |
| 104 | cellular response to zinc ion (GO:0071294) | 2.96415113 |
| 105 | lymphocyte costimulation (GO:0031294) | 2.96404851 |
| 106 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.94743328 |
| 107 | positive regulation of tolerance induction (GO:0002645) | 2.94399987 |
| 108 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.93473225 |
| 109 | cellular extravasation (GO:0045123) | 2.92912710 |
| 110 | cellular response to interferon-gamma (GO:0071346) | 2.92633768 |
| 111 | T-helper 1 type immune response (GO:0042088) | 2.91935389 |
| 112 | mature B cell differentiation (GO:0002335) | 2.91662397 |
| 113 | myeloid cell activation involved in immune response (GO:0002275) | 2.89998444 |
| 114 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.89607035 |
| 115 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.87650718 |
| 116 | respiratory burst (GO:0045730) | 2.86910740 |
| 117 | regulation of regulatory T cell differentiation (GO:0045589) | 2.86732420 |
| 118 | natural killer cell differentiation (GO:0001779) | 2.86461378 |
| 119 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.85816772 |
| 120 | mast cell activation (GO:0045576) | 2.84890433 |
| 121 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.84658468 |
| 122 | T cell receptor signaling pathway (GO:0050852) | 2.84266063 |
| 123 | regulation of type 2 immune response (GO:0002828) | 2.82900915 |
| 124 | neutrophil activation (GO:0042119) | 2.80689666 |
| 125 | natural killer cell activation (GO:0030101) | 2.79617284 |
| 126 | leukocyte cell-cell adhesion (GO:0007159) | 2.79605396 |
| 127 | dendritic cell chemotaxis (GO:0002407) | 2.79506220 |
| 128 | response to muramyl dipeptide (GO:0032495) | 2.77901637 |
| 129 | lymphocyte homeostasis (GO:0002260) | 2.75880601 |
| 130 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.75455344 |
| 131 | negative regulation of phagocytosis (GO:0050765) | 2.74234904 |
| 132 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.73845997 |
| 133 | positive regulation of B cell mediated immunity (GO:0002714) | 2.73845997 |
| 134 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.70399814 |
| 135 | viral transcription (GO:0019083) | 2.69725246 |
| 136 | positive regulation of interferon-beta production (GO:0032728) | 2.66093366 |
| 137 | negative regulation of interleukin-12 production (GO:0032695) | 2.64941488 |
| 138 | regulation of natural killer cell differentiation (GO:0032823) | 2.61927889 |
| 139 | neutrophil activation involved in immune response (GO:0002283) | 2.61575114 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.62434068 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.71032105 |
| 3 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.23762002 |
| 4 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.08504507 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.06539849 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.02745939 |
| 7 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.45192432 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.21716658 |
| 9 | MYC_22102868_ChIP-Seq_BL_Human | 2.93584431 |
| 10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.91069860 |
| 11 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.87449016 |
| 12 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.79458940 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.76557175 |
| 14 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.70863722 |
| 15 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.60689814 |
| 16 | MYB_26560356_Chip-Seq_TH2_Human | 2.53995417 |
| 17 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.53384928 |
| 18 | MAF_26560356_Chip-Seq_TH1_Human | 2.52508223 |
| 19 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.52157426 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.46030134 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.36017319 |
| 22 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.35029045 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.31587040 |
| 24 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.28341402 |
| 25 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.28046873 |
| 26 | MYB_26560356_Chip-Seq_TH1_Human | 2.25260672 |
| 27 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.23970867 |
| 28 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.17223404 |
| 29 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.07764866 |
| 30 | UTX_26944678_Chip-Seq_JUKART_Human | 2.04722082 |
| 31 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.97393741 |
| 32 | GATA1_22025678_ChIP-Seq_K562_Human | 1.95494514 |
| 33 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.95321476 |
| 34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.92191285 |
| 35 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.91320147 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.91172574 |
| 37 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.82183688 |
| 38 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.81428861 |
| 39 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.81348375 |
| 40 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.78289885 |
| 41 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.78009594 |
| 42 | MAF_26560356_Chip-Seq_TH2_Human | 1.66597873 |
| 43 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.62440312 |
| 44 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.61546317 |
| 45 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60221225 |
| 46 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.57175200 |
| 47 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.53476057 |
| 48 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.49259486 |
| 49 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.46695397 |
| 50 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46090701 |
| 51 | SPI1_23127762_ChIP-Seq_K562_Human | 1.45450192 |
| 52 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.43990473 |
| 53 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.41626496 |
| 54 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.40189374 |
| 55 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.39198460 |
| 56 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38998827 |
| 57 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.36578470 |
| 58 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.34920859 |
| 59 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.33268484 |
| 60 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.33236177 |
| 61 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.31052056 |
| 62 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.31038884 |
| 63 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.26453209 |
| 64 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25424794 |
| 65 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.23037669 |
| 66 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.19178880 |
| 67 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.17451613 |
| 68 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.16416211 |
| 69 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.15255714 |
| 70 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.10146909 |
| 71 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09799527 |
| 72 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09386062 |
| 73 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08885031 |
| 74 | GATA3_26560356_Chip-Seq_TH2_Human | 1.08760788 |
| 75 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.07042406 |
| 76 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.04565613 |
| 77 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04126069 |
| 78 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.00877135 |
| 79 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.00352101 |
| 80 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.00008243 |
| 81 | GATA1_19941826_ChIP-Seq_K562_Human | 0.99465351 |
| 82 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.98579578 |
| 83 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.98433418 |
| 84 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.97738703 |
| 85 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.97481888 |
| 86 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.96846928 |
| 87 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.94606480 |
| 88 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.94586446 |
| 89 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.94574502 |
| 90 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94491205 |
| 91 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90097488 |
| 92 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88866151 |
| 93 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.88837308 |
| 94 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86737191 |
| 95 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.85517318 |
| 96 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.84794573 |
| 97 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.84572779 |
| 98 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.84542573 |
| 99 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.82499531 |
| 100 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.82391318 |
| 101 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.82250481 |
| 102 | * VDR_23849224_ChIP-Seq_CD4+_Human | 0.82175155 |
| 103 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.80364102 |
| 104 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.78027384 |
| 105 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.77947107 |
| 106 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77540475 |
| 107 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.76616689 |
| 108 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.76548515 |
| 109 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75541864 |
| 110 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.73710054 |
| 111 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.72726365 |
| 112 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.72676325 |
| 113 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.72242470 |
| 114 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.69900860 |
| 115 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.69310991 |
| 116 | P300_27268052_Chip-Seq_Bcells_Human | 0.68911196 |
| 117 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.68784013 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * MP0001835_abnormal_antigen_presentation | 4.44520275 |
| 2 | MP0000685_abnormal_immune_system | 3.68512055 |
| 3 | MP0005671_abnormal_response_to | 3.36205002 |
| 4 | MP0001790_abnormal_immune_system | 3.22779563 |
| 5 | MP0005387_immune_system_phenotype | 3.22779563 |
| 6 | MP0001800_abnormal_humoral_immune | 3.14498658 |
| 7 | MP0003763_abnormal_thymus_physiology | 3.06913799 |
| 8 | * MP0009785_altered_susceptibility_to | 3.00402538 |
| 9 | MP0003436_decreased_susceptibility_to | 2.93104522 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.85479781 |
| 11 | MP0002166_altered_tumor_susceptibility | 2.79092679 |
| 12 | * MP0005025_abnormal_response_to | 2.71271671 |
| 13 | * MP0002452_abnormal_antigen_presenting | 2.70960768 |
| 14 | MP0002723_abnormal_immune_serum | 2.67716337 |
| 15 | * MP0002420_abnormal_adaptive_immunity | 2.55680016 |
| 16 | * MP0001819_abnormal_immune_cell | 2.54566341 |
| 17 | MP0003303_peritoneal_inflammation | 2.47265438 |
| 18 | MP0002148_abnormal_hypersensitivity_rea | 2.39628565 |
| 19 | * MP0002398_abnormal_bone_marrow | 2.36019336 |
| 20 | MP0003724_increased_susceptibility_to | 2.33907130 |
| 21 | MP0002419_abnormal_innate_immunity | 2.29798272 |
| 22 | MP0002006_tumorigenesis | 2.29590678 |
| 23 | MP0002396_abnormal_hematopoietic_system | 2.27017944 |
| 24 | * MP0000716_abnormal_immune_system | 2.16193549 |
| 25 | MP0004947_skin_inflammation | 2.15836429 |
| 26 | MP0004510_myositis | 2.14939640 |
| 27 | MP0006082_CNS_inflammation | 2.08862322 |
| 28 | MP0003300_gastrointestinal_ulcer | 2.08782623 |
| 29 | MP0010155_abnormal_intestine_physiology | 2.07732423 |
| 30 | MP0002405_respiratory_system_inflammati | 2.04475207 |
| 31 | MP0001873_stomach_inflammation | 2.03492718 |
| 32 | MP0005464_abnormal_platelet_physiology | 2.00351193 |
| 33 | MP0001853_heart_inflammation | 1.99921065 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.99855145 |
| 35 | MP0000689_abnormal_spleen_morphology | 1.96300802 |
| 36 | MP0002722_abnormal_immune_system | 1.91293294 |
| 37 | MP0005451_abnormal_body_composition | 1.85441728 |
| 38 | * MP0002429_abnormal_blood_cell | 1.82142562 |
| 39 | MP0001845_abnormal_inflammatory_respons | 1.77873078 |
| 40 | MP0004808_abnormal_hematopoietic_stem | 1.65472807 |
| 41 | MP0000703_abnormal_thymus_morphology | 1.63783350 |
| 42 | MP0003866_abnormal_defecation | 1.62219169 |
| 43 | MP0001545_abnormal_hematopoietic_system | 1.57651177 |
| 44 | MP0005397_hematopoietic_system_phenotyp | 1.57651177 |
| 45 | MP0000465_gastrointestinal_hemorrhage | 1.45080543 |
| 46 | MP0008469_abnormal_protein_level | 1.43372934 |
| 47 | MP0001533_abnormal_skeleton_physiology | 1.43021652 |
| 48 | MP0009278_abnormal_bone_marrow | 1.41999112 |
| 49 | MP0008260_abnormal_autophagy | 1.36118065 |
| 50 | MP0005310_abnormal_salivary_gland | 1.32188022 |
| 51 | MP0002254_reproductive_system_inflammat | 1.31654425 |
| 52 | MP0010352_gastrointestinal_tract_polyps | 1.29318644 |
| 53 | MP0003191_abnormal_cellular_cholesterol | 1.28779120 |
| 54 | MP0000858_altered_metastatic_potential | 1.27108696 |
| 55 | MP0003448_altered_tumor_morphology | 1.27101094 |
| 56 | MP0009764_decreased_sensitivity_to | 1.20204786 |
| 57 | MP0002933_joint_inflammation | 1.18989546 |
| 58 | MP0002138_abnormal_hepatobiliary_system | 1.18819305 |
| 59 | MP0000490_abnormal_crypts_of | 1.12813612 |
| 60 | MP0009840_abnormal_foam_cell | 1.08643307 |
| 61 | MP0005058_abnormal_lysosome_morphology | 1.02492118 |
| 62 | MP0002019_abnormal_tumor_incidence | 0.99252055 |
| 63 | MP0002277_abnormal_respiratory_mucosa | 0.98684889 |
| 64 | MP0005174_abnormal_tail_pigmentation | 0.98495713 |
| 65 | MP0003806_abnormal_nucleotide_metabolis | 0.96559481 |
| 66 | MP0003453_abnormal_keratinocyte_physiol | 0.96466505 |
| 67 | MP0005023_abnormal_wound_healing | 0.92009078 |
| 68 | MP0001851_eye_inflammation | 0.91610747 |
| 69 | MP0000343_altered_response_to | 0.88063072 |
| 70 | MP0009763_increased_sensitivity_to | 0.87934653 |
| 71 | MP0004883_abnormal_blood_vessel | 0.87510693 |
| 72 | MP0005164_abnormal_response_to | 0.87285668 |
| 73 | MP0005075_abnormal_melanosome_morpholog | 0.84976656 |
| 74 | MP0008004_abnormal_stomach_pH | 0.84783568 |
| 75 | MP0003172_abnormal_lysosome_physiology | 0.84388850 |
| 76 | MP0010307_abnormal_tumor_latency | 0.83214737 |
| 77 | MP0002998_abnormal_bone_remodeling | 0.82342088 |
| 78 | MP0003566_abnormal_cell_adhesion | 0.79550635 |
| 79 | MP0004381_abnormal_hair_follicle | 0.73144822 |
| 80 | MP0005076_abnormal_cell_differentiation | 0.72316082 |
| 81 | MP0000609_abnormal_liver_physiology | 0.70924920 |
| 82 | MP0001216_abnormal_epidermal_layer | 0.70764477 |
| 83 | MP0003690_abnormal_glial_cell | 0.70439546 |
| 84 | MP0010234_abnormal_vibrissa_follicle | 0.68384047 |
| 85 | MP0003795_abnormal_bone_structure | 0.67886520 |
| 86 | MP0002139_abnormal_hepatobiliary_system | 0.67709575 |
| 87 | MP0003183_abnormal_peptide_metabolism | 0.66431657 |
| 88 | MP0008874_decreased_physiological_sensi | 0.65496038 |
| 89 | MP0000604_amyloidosis | 0.64724024 |
| 90 | MP0002136_abnormal_kidney_physiology | 0.64544179 |
| 91 | MP0009765_abnormal_xenobiotic_induced | 0.64149743 |
| 92 | MP0001663_abnormal_digestive_system | 0.63966913 |
| 93 | MP0006054_spinal_hemorrhage | 0.62354048 |
| 94 | MP0002332_abnormal_exercise_endurance | 0.62184617 |
| 95 | MP0003045_fibrosis | 0.61969825 |
| 96 | MP0000249_abnormal_blood_vessel | 0.60778603 |
| 97 | MP0002132_abnormal_respiratory_system | 0.60266098 |
| 98 | MP0003828_pulmonary_edema | 0.60053656 |
| 99 | MP0003693_abnormal_embryo_hatching | 0.59933149 |
| 100 | MP0005166_decreased_susceptibility_to | 0.59700261 |
| 101 | MP0008057_abnormal_DNA_replication | 0.58493337 |
| 102 | MP0002095_abnormal_skin_pigmentation | 0.58412423 |
| 103 | MP0001348_abnormal_lacrimal_gland | 0.58062870 |
| 104 | MP0002009_preneoplasia | 0.57486853 |
| 105 | MP0005390_skeleton_phenotype | 0.55846132 |
| 106 | MP0009931_abnormal_skin_appearance | 0.55567219 |
| 107 | MP0003075_altered_response_to | 0.55476214 |
| 108 | MP0003091_abnormal_cell_migration | 0.55212172 |
| 109 | MP0005381_digestive/alimentary_phenotyp | 0.55079226 |
| 110 | MP0001191_abnormal_skin_condition | 0.54953405 |
| 111 | MP0000598_abnormal_liver_morphology | 0.54067599 |
| 112 | MP0003077_abnormal_cell_cycle | 0.53730876 |
| 113 | MP0000477_abnormal_intestine_morphology | 0.53208674 |
| 114 | MP0002877_abnormal_melanocyte_morpholog | 0.50091324 |
| 115 | MP0002693_abnormal_pancreas_physiology | 0.49110900 |
| 116 | MP0003329_amyloid_beta_deposits | 0.48703000 |
| 117 | MP0005319_abnormal_enzyme/_coenzyme | 0.48374847 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.21721353 |
| 2 | Eczematoid dermatitis (HP:0000976) | 4.88719746 |
| 3 | * Chronic otitis media (HP:0000389) | 4.67916123 |
| 4 | Recurrent viral infections (HP:0004429) | 4.59938354 |
| 5 | Recurrent abscess formation (HP:0002722) | 4.46873026 |
| 6 | Recurrent fungal infections (HP:0002841) | 4.37473495 |
| 7 | Myositis (HP:0100614) | 4.24199187 |
| 8 | * Recurrent bronchitis (HP:0002837) | 4.22434965 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 4.12184003 |
| 10 | IgM deficiency (HP:0002850) | 4.03703854 |
| 11 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.96316127 |
| 12 | Panhypogammaglobulinemia (HP:0003139) | 3.79623499 |
| 13 | * Nasal polyposis (HP:0100582) | 3.76562471 |
| 14 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.75140177 |
| 15 | Recurrent cutaneous fungal infections (HP:0011370) | 3.75140177 |
| 16 | T lymphocytopenia (HP:0005403) | 3.75093725 |
| 17 | Abnormality of T cell number (HP:0011839) | 3.71659200 |
| 18 | Abnormality of T cells (HP:0002843) | 3.69622081 |
| 19 | Agammaglobulinemia (HP:0004432) | 3.65586233 |
| 20 | Autoimmune thrombocytopenia (HP:0001973) | 3.59527453 |
| 21 | Thrombocytosis (HP:0001894) | 3.55560850 |
| 22 | Pustule (HP:0200039) | 3.49540738 |
| 23 | Inflammation of the large intestine (HP:0002037) | 3.48966213 |
| 24 | * Abnormality of the nasal mucosa (HP:0000433) | 3.48685329 |
| 25 | Vasculitis (HP:0002633) | 3.48144855 |
| 26 | Abnormality of T cell physiology (HP:0011840) | 3.47410627 |
| 27 | Increased IgE level (HP:0003212) | 3.46249974 |
| 28 | Gastrointestinal inflammation (HP:0004386) | 3.42980698 |
| 29 | Recurrent skin infections (HP:0001581) | 3.42827203 |
| 30 | Cellulitis (HP:0100658) | 3.41349664 |
| 31 | Colitis (HP:0002583) | 3.41030357 |
| 32 | Meningitis (HP:0001287) | 3.39573910 |
| 33 | Mediastinal lymphadenopathy (HP:0100721) | 3.36536456 |
| 34 | Interstitial pulmonary disease (HP:0006530) | 3.20275316 |
| 35 | Stomatitis (HP:0010280) | 3.18408098 |
| 36 | Lymphopenia (HP:0001888) | 3.10926357 |
| 37 | Spontaneous hematomas (HP:0007420) | 3.07688817 |
| 38 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.04952058 |
| 39 | Hypergammaglobulinemia (HP:0010702) | 2.97726911 |
| 40 | Orchitis (HP:0100796) | 2.96979550 |
| 41 | IgG deficiency (HP:0004315) | 2.96085923 |
| 42 | Abnormality of the fingertips (HP:0001211) | 2.93428429 |
| 43 | Gastrointestinal stroma tumor (HP:0100723) | 2.91425899 |
| 44 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.87263444 |
| 45 | Abnormality of macrophages (HP:0004311) | 2.86966108 |
| 46 | Systemic lupus erythematosus (HP:0002725) | 2.85718832 |
| 47 | Petechiae (HP:0000967) | 2.84066315 |
| 48 | B lymphocytopenia (HP:0010976) | 2.80410211 |
| 49 | Abnormality of B cell number (HP:0010975) | 2.80410211 |
| 50 | Eosinophilia (HP:0001880) | 2.72525527 |
| 51 | Chronic obstructive pulmonary disease (HP:0006510) | 2.72179652 |
| 52 | Obstructive lung disease (HP:0006536) | 2.72179652 |
| 53 | Optic neuritis (HP:0100653) | 2.71507607 |
| 54 | Retrobulbar optic neuritis (HP:0100654) | 2.71507607 |
| 55 | Increased IgM level (HP:0003496) | 2.68372315 |
| 56 | IgA deficiency (HP:0002720) | 2.67830501 |
| 57 | Gangrene (HP:0100758) | 2.67700104 |
| 58 | Recurrent sinusitis (HP:0011108) | 2.67070537 |
| 59 | Gingival bleeding (HP:0000225) | 2.66124971 |
| 60 | Severe combined immunodeficiency (HP:0004430) | 2.63292546 |
| 61 | Chronic diarrhea (HP:0002028) | 2.62308239 |
| 62 | Periodontitis (HP:0000704) | 2.61937659 |
| 63 | Combined immunodeficiency (HP:0005387) | 2.61910399 |
| 64 | Autoimmune hemolytic anemia (HP:0001890) | 2.61481902 |
| 65 | Leukocytosis (HP:0001974) | 2.61294324 |
| 66 | Verrucae (HP:0200043) | 2.61088282 |
| 67 | Papilloma (HP:0012740) | 2.61088282 |
| 68 | Granulocytopenia (HP:0001913) | 2.60900403 |
| 69 | Hemoptysis (HP:0002105) | 2.57056355 |
| 70 | Abnormality of glycolipid metabolism (HP:0010969) | 2.56610081 |
| 71 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.56610081 |
| 72 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.56610081 |
| 73 | Prolonged bleeding time (HP:0003010) | 2.56349328 |
| 74 | Pulmonary embolism (HP:0002204) | 2.54801731 |
| 75 | Pulmonary infiltrates (HP:0002113) | 2.54639289 |
| 76 | Epistaxis (HP:0000421) | 2.52602453 |
| 77 | Abnormality of the pleura (HP:0002103) | 2.51972910 |
| 78 | Anorexia (HP:0002039) | 2.48522394 |
| 79 | Abnormality of eosinophils (HP:0001879) | 2.47600650 |
| 80 | Encephalitis (HP:0002383) | 2.47290500 |
| 81 | Thyroiditis (HP:0100646) | 2.46060875 |
| 82 | * Emphysema (HP:0002097) | 2.44658061 |
| 83 | Arterial thrombosis (HP:0004420) | 2.44506612 |
| 84 | Malnutrition (HP:0004395) | 2.42042851 |
| 85 | Osteomyelitis (HP:0002754) | 2.41351286 |
| 86 | * Skin ulcer (HP:0200042) | 2.41282994 |
| 87 | Gingivitis (HP:0000230) | 2.39548843 |
| 88 | * Chronic sinusitis (HP:0011109) | 2.38397385 |
| 89 | Lymphoma (HP:0002665) | 2.31977160 |
| 90 | Hematochezia (HP:0002573) | 2.30952441 |
| 91 | Premature loss of primary teeth (HP:0006323) | 2.30534976 |
| 92 | Chest pain (HP:0100749) | 2.26900882 |
| 93 | Gastrointestinal infarctions (HP:0005244) | 2.26712098 |
| 94 | * Bronchitis (HP:0012387) | 2.24575180 |
| 95 | Joint swelling (HP:0001386) | 2.22270476 |
| 96 | Glomerulopathy (HP:0100820) | 2.21890172 |
| 97 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.16613080 |
| 98 | Restrictive lung disease (HP:0002091) | 2.16229201 |
| 99 | Basal ganglia calcification (HP:0002135) | 2.15405169 |
| 100 | Arthralgia (HP:0002829) | 2.12287566 |
| 101 | Abnormal platelet volume (HP:0011876) | 2.11793245 |
| 102 | Peritonitis (HP:0002586) | 2.11361321 |
| 103 | Abnormality of the pericardium (HP:0001697) | 2.09659132 |
| 104 | Amyloidosis (HP:0011034) | 2.09018088 |
| 105 | Hypochromic anemia (HP:0001931) | 2.06899624 |
| 106 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.06661901 |
| 107 | Episodic fever (HP:0001954) | 2.05468916 |
| 108 | Abnormal platelet function (HP:0011869) | 2.05369215 |
| 109 | Impaired platelet aggregation (HP:0003540) | 2.05369215 |
| 110 | Abnormality of the endocardium (HP:0004306) | 2.05364047 |
| 111 | Keratoconjunctivitis sicca (HP:0001097) | 2.04752179 |
| 112 | Skin rash (HP:0000988) | 2.03803074 |
| 113 | Abnormality of the peritoneum (HP:0002585) | 2.03796486 |
| 114 | Urticaria (HP:0001025) | 2.02881436 |
| 115 | Polyneuropathy (HP:0001271) | 2.01049755 |
| 116 | Cheilitis (HP:0100825) | 1.99362982 |
| 117 | Keratitis (HP:0000491) | 1.98671424 |
| 118 | Recurrent lower respiratory tract infections (HP:0002783) | 1.98620922 |
| 119 | Increased serum ferritin (HP:0003281) | 1.98170818 |
| 120 | Sepsis (HP:0100806) | 1.97835332 |
| 121 | Dysostosis multiplex (HP:0000943) | 1.97715641 |
| 122 | Purpura (HP:0000979) | 1.97027790 |
| 123 | Keratoconjunctivitis (HP:0001096) | 1.96483057 |
| 124 | Loss of speech (HP:0002371) | 1.95832055 |
| 125 | Fatigue (HP:0012378) | 1.95665282 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 5.04021521 |
| 2 | TYK2 | 3.57788869 |
| 3 | JAK3 | 3.34590152 |
| 4 | PRPF4B | 2.86802200 |
| 5 | IKBKE | 2.81895914 |
| 6 | FGFR4 | 2.78283157 |
| 7 | TXK | 2.68612422 |
| 8 | KIT | 2.66176248 |
| 9 | TBK1 | 2.64227539 |
| 10 | MAP3K14 | 2.61990539 |
| 11 | BLK | 2.54681737 |
| 12 | ZAP70 | 2.33017985 |
| 13 | JAK1 | 2.31652257 |
| 14 | ERN1 | 2.18342361 |
| 15 | EEF2K | 2.11759157 |
| 16 | STK10 | 1.96078208 |
| 17 | BTK | 1.95292876 |
| 18 | IKBKB | 1.77427009 |
| 19 | MAP3K10 | 1.76516268 |
| 20 | ITK | 1.76248169 |
| 21 | IRAK4 | 1.75546619 |
| 22 | GRK6 | 1.74264705 |
| 23 | SYK | 1.73250033 |
| 24 | CSF1R | 1.71226255 |
| 25 | FGFR3 | 1.70068400 |
| 26 | TEC | 1.64973535 |
| 27 | NME2 | 1.61571278 |
| 28 | MAP3K13 | 1.61135662 |
| 29 | LRRK2 | 1.52350938 |
| 30 | LCK | 1.47241112 |
| 31 | FLT3 | 1.42984328 |
| 32 | TAOK1 | 1.42680990 |
| 33 | EPHB1 | 1.41308310 |
| 34 | CSK | 1.38065493 |
| 35 | TAOK2 | 1.36532870 |
| 36 | NLK | 1.33935772 |
| 37 | FGR | 1.33688723 |
| 38 | HCK | 1.31022213 |
| 39 | PKN2 | 1.24491426 |
| 40 | TRIB3 | 1.20341005 |
| 41 | RPS6KA4 | 1.20199505 |
| 42 | SMG1 | 1.19952143 |
| 43 | TGFBR2 | 1.18269696 |
| 44 | MST4 | 1.14167498 |
| 45 | EPHA3 | 1.13968144 |
| 46 | KDR | 1.13763999 |
| 47 | PIM1 | 1.13188396 |
| 48 | RIPK4 | 1.12582044 |
| 49 | PIM2 | 1.11508675 |
| 50 | CHUK | 1.09926498 |
| 51 | BMPR2 | 1.08999905 |
| 52 | CDC42BPA | 1.06029497 |
| 53 | JAK2 | 1.03528400 |
| 54 | MAP2K3 | 1.00117637 |
| 55 | LYN | 0.99479669 |
| 56 | IRAK3 | 0.97122514 |
| 57 | FES | 0.95567243 |
| 58 | CLK1 | 0.95348450 |
| 59 | GRK7 | 0.94611048 |
| 60 | TAOK3 | 0.90641803 |
| 61 | MARK3 | 0.82958427 |
| 62 | KSR2 | 0.75210032 |
| 63 | TGFBR1 | 0.73198403 |
| 64 | PTK6 | 0.70962321 |
| 65 | SIK2 | 0.66839343 |
| 66 | PRKCQ | 0.65778690 |
| 67 | CDK4 | 0.62222896 |
| 68 | RPS6KB2 | 0.62205076 |
| 69 | MAPK11 | 0.59951940 |
| 70 | PRKD2 | 0.59645013 |
| 71 | PDPK1 | 0.58751840 |
| 72 | MAPK7 | 0.57341143 |
| 73 | STK4 | 0.57273816 |
| 74 | IRAK2 | 0.55715772 |
| 75 | MAP3K5 | 0.54525448 |
| 76 | YES1 | 0.52935002 |
| 77 | HIPK2 | 0.52711312 |
| 78 | TTN | 0.51853880 |
| 79 | SIK1 | 0.51365347 |
| 80 | MARK2 | 0.50930119 |
| 81 | FYN | 0.50788040 |
| 82 | NEK9 | 0.50011419 |
| 83 | TESK2 | 0.49791751 |
| 84 | MAP3K7 | 0.48245170 |
| 85 | MAP2K6 | 0.48034065 |
| 86 | MATK | 0.46781869 |
| 87 | CDK12 | 0.44874425 |
| 88 | MAPK12 | 0.44065941 |
| 89 | MAP3K8 | 0.44064481 |
| 90 | TNK2 | 0.43756630 |
| 91 | MAP3K11 | 0.43537314 |
| 92 | NEK2 | 0.42741693 |
| 93 | MAPKAPK3 | 0.42675355 |
| 94 | MAPK4 | 0.41305948 |
| 95 | CDK6 | 0.41048844 |
| 96 | MAP3K3 | 0.40536637 |
| 97 | SCYL2 | 0.40448661 |
| 98 | MOS | 0.40154104 |
| 99 | TRPM7 | 0.39739364 |
| 100 | PRKCH | 0.39736087 |
| 101 | IRAK1 | 0.39348986 |
| 102 | ABL1 | 0.37861416 |
| 103 | RPS6KA6 | 0.37604119 |
| 104 | RPS6KA5 | 0.37559790 |
| 105 | PDK1 | 0.36593936 |
| 106 | MAPKAPK2 | 0.35849335 |
| 107 | MAP3K6 | 0.35844542 |
| 108 | EGFR | 0.35148939 |
| 109 | DDR2 | 0.34061811 |
| 110 | ALK | 0.29463513 |
| 111 | SIK3 | 0.28036514 |
| 112 | PIK3CG | 0.27787096 |
| 113 | RET | 0.26945571 |
| 114 | PRKCD | 0.26334485 |
| 115 | DYRK1B | 0.25561394 |
| 116 | MAPK3 | 0.24957480 |
| 117 | STK24 | 0.23980858 |
| 118 | CAMKK1 | 0.23413774 |
| 119 | RPS6KC1 | 0.23371003 |
| 120 | RPS6KL1 | 0.23371003 |
| 121 | PASK | 0.22405406 |
| 122 | MAP3K1 | 0.21861734 |
| 123 | ATR | 0.20952848 |
| 124 | MST1R | 0.20680650 |
| 125 | RIPK1 | 0.20549122 |
| 126 | CDK9 | 0.20535488 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Primary immunodeficiency_Homo sapiens_hsa05340 | 3.89617718 |
| 2 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.84747959 |
| 3 | Measles_Homo sapiens_hsa05162 | 2.73411534 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.73215802 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.69678266 |
| 6 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.50780093 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.45660436 |
| 8 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.37012682 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.34356565 |
| 10 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 2.31491614 |
| 11 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.25226173 |
| 12 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.20193287 |
| 13 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.09903385 |
| 14 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.08747788 |
| 15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.04124838 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.98278771 |
| 17 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.97571651 |
| 18 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.91453630 |
| 19 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.90774962 |
| 20 | Influenza A_Homo sapiens_hsa05164 | 1.78449984 |
| 21 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.76936883 |
| 22 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.63794513 |
| 23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.62882589 |
| 24 | Legionellosis_Homo sapiens_hsa05134 | 1.56027290 |
| 25 | Viral myocarditis_Homo sapiens_hsa05416 | 1.51339669 |
| 26 | Ribosome_Homo sapiens_hsa03010 | 1.50937638 |
| 27 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.48246503 |
| 28 | Pertussis_Homo sapiens_hsa05133 | 1.48027058 |
| 29 | Malaria_Homo sapiens_hsa05144 | 1.47730832 |
| 30 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.47372917 |
| 31 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.43958967 |
| 32 | Hepatitis B_Homo sapiens_hsa05161 | 1.43459166 |
| 33 | Apoptosis_Homo sapiens_hsa04210 | 1.41926339 |
| 34 | Tuberculosis_Homo sapiens_hsa05152 | 1.36037581 |
| 35 | Shigellosis_Homo sapiens_hsa05131 | 1.33178150 |
| 36 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.31691603 |
| 37 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.30634030 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.28150039 |
| 39 | Asthma_Homo sapiens_hsa05310 | 1.27490193 |
| 40 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.25416765 |
| 41 | Hepatitis C_Homo sapiens_hsa05160 | 1.24164651 |
| 42 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.23311864 |
| 43 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.22373013 |
| 44 | DNA replication_Homo sapiens_hsa03030 | 1.12688846 |
| 45 | * Phagosome_Homo sapiens_hsa04145 | 1.05982519 |
| 46 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.03697348 |
| 47 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.97240494 |
| 48 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.94310583 |
| 49 | Platelet activation_Homo sapiens_hsa04611 | 0.93655253 |
| 50 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91761437 |
| 51 | Salmonella infection_Homo sapiens_hsa05132 | 0.91472682 |
| 52 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.91167969 |
| 53 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.88641980 |
| 54 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.86560360 |
| 55 | Base excision repair_Homo sapiens_hsa03410 | 0.86048631 |
| 56 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.86000590 |
| 57 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.85580723 |
| 58 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.83504235 |
| 59 | HTLV-I infection_Homo sapiens_hsa05166 | 0.83410343 |
| 60 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.82349029 |
| 61 | Other glycan degradation_Homo sapiens_hsa00511 | 0.81572181 |
| 62 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.79001951 |
| 63 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.78860677 |
| 64 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.74200844 |
| 65 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.72898766 |
| 66 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65487450 |
| 67 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.62879387 |
| 68 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56692222 |
| 69 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56288753 |
| 70 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.55976603 |
| 71 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.53746597 |
| 72 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.53316360 |
| 73 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.52966057 |
| 74 | Mismatch repair_Homo sapiens_hsa03430 | 0.51610636 |
| 75 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.50686154 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.48408259 |
| 77 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.47776531 |
| 78 | Lysosome_Homo sapiens_hsa04142 | 0.45850267 |
| 79 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.43349245 |
| 80 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.42149986 |
| 81 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.40598599 |
| 82 | Bladder cancer_Homo sapiens_hsa05219 | 0.37115778 |
| 83 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.35522860 |
| 84 | Sulfur relay system_Homo sapiens_hsa04122 | 0.34136447 |
| 85 | Prion diseases_Homo sapiens_hsa05020 | 0.33522494 |
| 86 | Colorectal cancer_Homo sapiens_hsa05210 | 0.32831522 |
| 87 | Amoebiasis_Homo sapiens_hsa05146 | 0.32565974 |
| 88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.32552776 |
| 89 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.31217939 |
| 90 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.30318220 |
| 91 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.29956638 |
| 92 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.29562453 |
| 93 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.29420752 |
| 94 | Homologous recombination_Homo sapiens_hsa03440 | 0.27728927 |
| 95 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.27447840 |
| 96 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.27436867 |
| 97 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.27312788 |
| 98 | Endometrial cancer_Homo sapiens_hsa05213 | 0.26255986 |
| 99 | Spliceosome_Homo sapiens_hsa03040 | 0.26172629 |
| 100 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.25804314 |
| 101 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.25149664 |
| 102 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.24019801 |
| 103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.23527711 |
| 104 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22886941 |
| 105 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.22408690 |
| 106 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.21691307 |
| 107 | Prostate cancer_Homo sapiens_hsa05215 | 0.20940382 |
| 108 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.20683780 |
| 109 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.20507590 |
| 110 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.20354633 |
| 111 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.19715388 |
| 112 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.19474350 |
| 113 | Endocytosis_Homo sapiens_hsa04144 | 0.19185640 |
| 114 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.19053015 |
| 115 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.17709194 |
| 116 | Galactose metabolism_Homo sapiens_hsa00052 | 0.17225115 |
| 117 | Pathways in cancer_Homo sapiens_hsa05200 | 0.16816974 |
| 118 | Proteasome_Homo sapiens_hsa03050 | 0.16339010 |
| 119 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.14358047 |

